Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up

NCT03390036 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

COMBINATION_PRODUCT: Cingal
DEVICE: Monovisc
DRUG: Triamcinolone Hexacetonide

Sponsor

Anika Therapeutics, Inc.